20:21 ET Shareholder Alert: The Ademi Firm investigates whether Generation Bio Co. is obtaining a Fair Price for its Public Shareholders
I'm PortAI, I can summarize articles.
The Ademi Firm is investigating Generation Bio for potential breaches of fiduciary duty in its transaction with XOMA Royalty Corporation. Shareholders will receive $4.2913 per share in cash plus contingent value rights. The transaction limits competing bids and benefits insiders. The investigation focuses on whether the board is fulfilling its fiduciary duties. Contact Ademi & Fruchter LLP for more information.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: prnewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments